Hillstream BioPharma, Inc. HILS
Day range unavailable
52-week range unavailable
- Market cap
- 5.94M
- Shares out
- 16.81M
- Forward P/E
- -2.08
- Analysts
- Buy
- Price target
- 4.00 (+1587.8%)
- Earnings date
- Nov 13, 2023
Key statistics
- Enterprise value
- 2.65M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 1.27
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -4.45M
- Total cash
- 3.57M
- Total debt
- 0
- Return on equity
- -121.41%
- Short % of float
- 1.47%
- 50-day average
- 0.38428
- 200-day average
- 0.66568
Analyst view
Consensus: buy
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 13, 2023
Expected Nov 13, 2023. Consensus EPS estimate -0.16.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2023 | Sep 1, 2023 | -0.05 | — | — | — |
| Aug 11, 2023 | Jun 1, 2023 | -0.16 | — | — | — |
| May 22, 2023 | Mar 1, 2023 | -0.11 | — | — | — |
| Mar 16, 2023 | Dec 1, 2022 | 0.00 | — | — | — |
| Nov 14, 2022 | Sep 1, 2022 | 0.00 | — | — | — |
About Hillstream BioPharma, Inc.
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-3215, an anti-HER2 monoclonal antibody candidate; and HSB-1940, a Quatrabody that is a proprietary IO biologic in development targeting PD-1. The company was incorporated in 2017 and is based in Bridgewater, New Jersey.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- hillstreambio.com
News
Why Okta Shares Are Trading Higher By 11%; Here Are 20 Stocks Moving Premarket 
Stocks That Hit 52-Week Lows On Tuesday 
Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session 
Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session 
Why First Republic Bank Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session 
Why Hitek Global Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket - 12 Health Care Stocks Moving In Thursday's Intraday Session
Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session 
Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session 
Why Hempacco Are Trading Lower By 58%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Your note
Sign in to keep a note on HILS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| APPAJOSYULA SIREESH | Director | Stock Gift | Jul 13, 2022 | 0 |
| MAZUR LEONARD L | Director | Purchase | Jan 13, 2022 | 123,733 |
| MILBY RANDY | Chief Executive Officer | Purchase | Jun 16, 2022 | 2,937,940 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Renaissance Technologies, LLC | 0.35% | 40,400 | 14.27K | Mar 30, 2023 |
| Geode Capital Management, LLC | 0.33% | 38,313 | 13.53K | Mar 30, 2023 |
| Virtu Financial LLC | 0.23% | 26,563 | 9.38K | Mar 30, 2023 |
| State Street Corporation | 0.22% | 25,768 | 9.10K | Mar 30, 2023 |
| Tower Research Capital LLC (TRC) | 0.10% | 11,828 | 4.18K | Mar 30, 2023 |
| UBS Group AG | 0.02% | 1,984 | 700 | Mar 30, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.33% | 38,313 | 13.53K | Feb 27, 2023 |